BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11555585)

  • 1. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer.
    Hadami K; Dakka N; Bensaid M; El Ahanidi H; Ameur A; Chahdi H; Oukabli M; Al Bouzidi A; Attaleb M; El Mzibri M
    Mol Genet Genomic Med; 2018 Sep; 6(5):819-827. PubMed ID: 30043549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
    Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
    Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical Assay of GSTP1-related DNA Sequence for Prostrate Cancer Screening.
    Saheb AH; Leon M; Josowicz M
    Electrochem Soc Interface; 2012; 21(3-4):71-75. PubMed ID: 25284970
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
    Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R; Jerónimo C
    Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
    Lee WH; Morton RA; Epstein JI; Brooks JD; Campbell PA; Bova GS; Hsieh WS; Isaacs WB; Nelson WG
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11733-7. PubMed ID: 7972132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
    Meiers I; Shanks JH; Bostwick DG
    Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
    Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
    Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
    Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary biomarkers for prostate cancer: a review.
    Hessels D; Schalken JA
    Asian J Androl; 2013 May; 15(3):333-9. PubMed ID: 23524531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epigenetic promise for prostate cancer diagnosis.
    Van Neste L; Herman JG; Otto G; Bigley JW; Epstein JI; Van Criekinge W
    Prostate; 2012 Aug; 72(11):1248-61. PubMed ID: 22161815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in cancer.
    Sharma S; Kelly TK; Jones PA
    Carcinogenesis; 2010 Jan; 31(1):27-36. PubMed ID: 19752007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in cancer.
    Esteller M
    N Engl J Med; 2008 Mar; 358(11):1148-59. PubMed ID: 18337604
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
    Jerónimo C; Usadel H; Henrique R; Oliveira J; Lopes C; Nelson WG; Sidransky D
    J Natl Cancer Inst; 2001 Nov; 93(22):1747-52. PubMed ID: 11717336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
    Eickelschulte S; Riediger AL; Angeles AK; Janke F; Duensing S; Sültmann H; Görtz M
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation profiles of global LINE-1 DNA and the GSTP1 promoter region in children exposed to lead (Pb).
    Yohannes YB; Nakayama SMM; Yabe J; Toyomaki H; Kataba A; Nakata H; Muzandu K; Miyashita C; Ikenaka Y; Choongo K; Ishizuka M
    Epigenetics; 2022 Dec; 17(13):2377-2388. PubMed ID: 36131534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.